Abstract
There are fewer multiple sclerosis patients in wheelchairs than ever before in South Africa, mainly due to the advent of interferon drugs over the last decade with better second line drugs over the past three years, says Prof. Girish Modi, Head of Neurology at the University of the Witwatersrand.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
